NDC 68210-0200-01 - IBUPROFEN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68210-0200
- Requested NDC
- 68210-0200-01
- Package NDCs from labels
- 68210-0200-1, 68210-0200-01
- Manufacturer
- SPIRIT PHARMACEUTICALS,LLC
- Effective date
- 2024-12-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| IBUPROFEN - SPIRIT PHARMACEUTICALS,LLC | SPIRIT PHARMACEUTICALS,LLC | 2024-12-30 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68210-0200-1 | IBUPROFEN | 10 in 1 BOTTLE | CAPSULE, LIQUID FILLED | 10 | 8 | |
| 68210-0200-1 | IBUPROFEN | 1 in 1 CARTON | CAPSULE, LIQUID FILLED | 1 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68210-0200 | IBUPROFEN CAPSULE, LIQUID FILLED [SPIRIT PHARMACEUTICALS,LLC] | 8 | Current NDC, Legacy NDC, 2 package rows | 20250101_2810122e-3c89-49a2-8dac-db3714cb7b45.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ibuprofen | IBUPROFEN | H E B | 21567c0f-abba-4a40-a0b9-5ce49b3d9648 | 2026-07-28 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | PD-Rx Pharmaceuticals, Inc. | 656658cc-8cf0-42b6-af4f-4e3ab7648625 | 2026-07-27 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | REMEDYREPACK INC. | a7756b22-73cf-4262-aa8e-0577ddecd03b | 2026-07-24 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Shield Pharmaceuticals Corp | 1ca722bb-940e-4b3e-9561-d87e2feb1ff8 | 2026-07-24 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Shield Pharmaceuticals Corp | fc6c29b4-f1b3-4cfe-8c96-564d083be39c | 2026-07-24 | Warnings | WK2XYI10QM |
| Neutraflush | EYEWASH STATION ADDITIVE CONCENTRATE | Aero Healthcare | 1d9ff2ef-9c9b-f367-e063-6294a90afa0e | 2026-07-24 | Warnings | 6DC9Q167V3 |
| childrens ibuprofen | IBUPROFEN | Rite Aid Corporation | 26bccfc1-bc8d-4241-a078-c760048951c9 | 2026-07-24 | Warnings | WK2XYI10QM |
| IBUPROFEN | IBUPROFEN | HF Acquisition Co LLC, DBA HealthFirst | 574b6f15-70bc-fca7-e063-6294a90a0455 | 2026-07-23 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Safeway, Inc. | a530d43d-e9c4-4edb-af66-c92860e46f45 | 2026-07-23 | Warnings | 310964 WK2XYI10QM |
| Ibuprofen | IBUPROFEN | TWIN MED LLC | f03958f8-aeae-edf0-e053-2a95a90a3e9e | 2026-07-22 | Warnings | WK2XYI10QM |
| Good Sense ibuprofen | IBUPROFEN | L. Perrigo Company | aebae4b3-18c8-4ecf-b578-1fe7cc50076b | 2026-07-22 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | PD-Rx Pharmaceuticals, Inc. | d3a7ebef-f7ab-4b34-b62e-278a8deabf78 | 2026-07-21 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | PD-Rx Pharmaceuticals, Inc. | b81c6495-8b30-41ef-8a0f-4cbfd87f1eb4 | 2026-07-21 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Sterile Water | WATER | Cardinal Health 107, LLC | 9655cd02-82b5-4a75-813b-854b19551481 | 2026-07-21 | Warnings, Adverse reactions | 059QF0KO0R |
| Ibuprofen | IBUPROFEN | PD-Rx Pharmaceuticals, Inc. | 0cb73c19-a7cb-4ad9-9aa5-c24afb80d6d8 | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Acetaminophen and Ibuprofen | ACETAMINOPHEN AND IBUPROFEN | CVS Pharmacy | 52193849-d03a-b61b-e063-6394a90ad277 | 2026-07-20 | Warnings | WK2XYI10QM |
| good sense dual action | ACETAMINOPHEN, IBUPROFEN | L Perrigo Company | b117358c-f4ca-4ea8-95ee-88a42cc05040 | 2026-07-17 | Warnings | WK2XYI10QM |
| FUNGAL NAIL TREATMENT kit .cream. | PSEUDOLARIX AMABILIS BARK 1% | GETHSEMANE BRANCH CORPORATION | 56c9d9fa-09ad-e26a-e063-6394a90a0ed9 | 2026-07-17 | Warnings | 6DC9Q167V3 |
| Ibuprofen | IBUPROFEN | REMEDYREPACK INC. | 57a1bf99-5aaf-432d-86ba-5f0e7cfab1a0 | 2026-07-17 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Eyewash Station Additive Concentrate | CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL | Global Equipment Company | bc93a1e8-aa3c-6735-e053-2995a90ad6e8 | 2026-07-16 | Warnings | 6DC9Q167V3 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.